137 related articles for article (PubMed ID: 16440290)
41. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.
Tjandra SS; Hsu C; Goh YI; Gurung A; Poon R; Nadesan P; Alman BA
Cancer Res; 2007 Aug; 67(15):7124-31. PubMed ID: 17671179
[TBL] [Abstract][Full Text] [Related]
42. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
[TBL] [Abstract][Full Text] [Related]
43. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI
Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329
[TBL] [Abstract][Full Text] [Related]
44. β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis.
Huss S; Nehles J; Binot E; Wardelmann E; Mittler J; Kleine MA; Künstlinger H; Hartmann W; Hohenberger P; Merkelbach-Bruse S; Buettner R; Schildhaus HU
Histopathology; 2013 Jan; 62(2):294-304. PubMed ID: 23020601
[TBL] [Abstract][Full Text] [Related]
45. Modulation of signal transducers and activators of transcription (STAT) factor pathways during focal cerebral ischaemia: a gene expression array study in rat hippocampus after middle cerebral artery occlusion.
Sun SL; Li TJ; Yang PY; Qiu Y; Rui YC
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1097-101. PubMed ID: 17880360
[TBL] [Abstract][Full Text] [Related]
46. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
Rebouissou S; Couchy G; Libbrecht L; Balabaud C; Imbeaud S; Auffray C; Roskams T; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2008 Jul; 49(1):61-71. PubMed ID: 18466996
[TBL] [Abstract][Full Text] [Related]
47. Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: a study of 100 cases.
Thway K; Gibson S; Ramsay A; Sebire NJ
Pediatr Dev Pathol; 2009; 12(4):292-6. PubMed ID: 18939887
[TBL] [Abstract][Full Text] [Related]
48. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.
Fattet S; Haberler C; Legoix P; Varlet P; Lellouch-Tubiana A; Lair S; Manie E; Raquin MA; Bours D; Carpentier S; Barillot E; Grill J; Doz F; Puget S; Janoueix-Lerosey I; Delattre O
J Pathol; 2009 May; 218(1):86-94. PubMed ID: 19197950
[TBL] [Abstract][Full Text] [Related]
49. Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP.
Harjunpää A; Taskinen M; Nykter M; Karjalainen-Lindsberg ML; Nyman H; Monni O; Hemmer S; Yli-Harja O; Hautaniemi S; Meri S; Leppä S
Br J Haematol; 2006 Oct; 135(1):33-42. PubMed ID: 16925574
[TBL] [Abstract][Full Text] [Related]
50. Nodular fasciitis of the head and neck region: a clinicopathologic description in a series of 30 cases.
Weinreb I; Shaw AJ; Perez-Ordoñez B; Goldblum JR; Rubin BP
J Cutan Pathol; 2009 Nov; 36(11):1168-73. PubMed ID: 19469872
[TBL] [Abstract][Full Text] [Related]
51. Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis.
Zhou L; Xu H; Zhou J; Dong L; Zhang P; Yang X; Wang C
Diagn Pathol; 2019 May; 14(1):34. PubMed ID: 31043173
[TBL] [Abstract][Full Text] [Related]
52. TGF-β and CTGF are Mitogenic Output Mediators of Wnt/β-Catenin Signaling in Desmoid Fibromatosis.
Varghese S; Braggio DA; Gillespie J; Toland AE; Pollock R; Mayerson J; Scharschmidt T; Iwenofu OH
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):559-565. PubMed ID: 26894649
[TBL] [Abstract][Full Text] [Related]
53. Transcripts from a human primordial follicle cDNA library.
Serafica MD; Goto T; Trounson AO
Hum Reprod; 2005 Aug; 20(8):2074-91. PubMed ID: 15845590
[TBL] [Abstract][Full Text] [Related]
54. Gene expression profiling of human sarcomas: insights into sarcoma biology.
Baird K; Davis S; Antonescu CR; Harper UL; Walker RL; Chen Y; Glatfelter AA; Duray PH; Meltzer PS
Cancer Res; 2005 Oct; 65(20):9226-35. PubMed ID: 16230383
[TBL] [Abstract][Full Text] [Related]
55. Photoperiod-induced differential expression of angiogenesis genes in testes of adult Peromyscus leucopus.
Pyter LM; Hotchkiss AK; Nelson RJ
Reproduction; 2005 Feb; 129(2):201-9. PubMed ID: 15695614
[TBL] [Abstract][Full Text] [Related]
56. Immunoreactivity for calretinin and keratins in desmoid fibromatosis and other myofibroblastic tumors: a diagnostic pitfall.
Barak S; Wang Z; Miettinen M
Am J Surg Pathol; 2012 Sep; 36(9):1404-9. PubMed ID: 22531174
[TBL] [Abstract][Full Text] [Related]
57. Clinico-pathologic correlations of myofibroblastic tumors of the oral cavity: 1. Nodular fasciitis.
Dayan D; Nasrallah V; Vered M
J Oral Pathol Med; 2005 Aug; 34(7):426-35. PubMed ID: 16011613
[TBL] [Abstract][Full Text] [Related]
58. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.
Bhattacharya B; Dilworth HP; Iacobuzio-Donahue C; Ricci F; Weber K; Furlong MA; Fisher C; Montgomery E
Am J Surg Pathol; 2005 May; 29(5):653-9. PubMed ID: 15832090
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic and behavioural parameters differentiating proliferative muscolo-fascial low grade lesions. Case reports.
Pasta V; Chiarini S; Redler A; Monti M
G Chir; 2010; 31(11-12):491-6. PubMed ID: 21232190
[TBL] [Abstract][Full Text] [Related]
60. 'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis.
Colombo C; Bolshakov S; Hajibashi S; Lopez-Terrada L; Wang WL; Rao P; Benjamin RS; Lazar AJ; Lev D
Histopathology; 2011 Aug; 59(2):336-40. PubMed ID: 21884214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
